New combo therapy aims to tackle tough bone cancer

NCT ID NCT07620431

Not yet recruiting Disease control Sponsor: Peking University People's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether giving radiation and chemotherapy together before surgery can help control high-risk Ewing sarcoma, a type of bone cancer. Researchers will follow 55 patients to see how well the treatment works and how safe it is. The goal is to improve local tumor control and survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radiation therapy and chemotherapy before surgery
What this could lead to: If successful, this approach could improve local tumor control and survival for patients with high-risk Ewing sarcoma.
What could go wrong: This is a small, single-center observational study, not a randomized trial. Results may not apply broadly, and there are risks of wound complications and infections from the combined treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bone cancer bone neoplasm Ewing sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BONE NEOPLASMS EWING SARCOMA

Contacts and locations

Locations

Peking University People's Hospital, Beijing, Beijing 100044

Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.